全文获取类型
收费全文 | 3617篇 |
免费 | 166篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 72篇 |
妇产科学 | 45篇 |
基础医学 | 336篇 |
口腔科学 | 134篇 |
临床医学 | 203篇 |
内科学 | 1186篇 |
皮肤病学 | 73篇 |
神经病学 | 205篇 |
特种医学 | 193篇 |
外科学 | 514篇 |
综合类 | 12篇 |
一般理论 | 1篇 |
预防医学 | 96篇 |
眼科学 | 34篇 |
药学 | 234篇 |
中国医学 | 5篇 |
肿瘤学 | 381篇 |
出版年
2024年 | 2篇 |
2023年 | 25篇 |
2022年 | 78篇 |
2021年 | 151篇 |
2020年 | 64篇 |
2019年 | 90篇 |
2018年 | 103篇 |
2017年 | 74篇 |
2016年 | 102篇 |
2015年 | 92篇 |
2014年 | 97篇 |
2013年 | 160篇 |
2012年 | 235篇 |
2011年 | 236篇 |
2010年 | 116篇 |
2009年 | 121篇 |
2008年 | 211篇 |
2007年 | 236篇 |
2006年 | 228篇 |
2005年 | 233篇 |
2004年 | 228篇 |
2003年 | 211篇 |
2002年 | 214篇 |
2001年 | 34篇 |
2000年 | 44篇 |
1999年 | 40篇 |
1998年 | 36篇 |
1997年 | 37篇 |
1996年 | 36篇 |
1995年 | 16篇 |
1994年 | 21篇 |
1993年 | 12篇 |
1992年 | 18篇 |
1991年 | 17篇 |
1990年 | 14篇 |
1989年 | 21篇 |
1988年 | 17篇 |
1987年 | 17篇 |
1986年 | 14篇 |
1985年 | 14篇 |
1984年 | 16篇 |
1983年 | 19篇 |
1982年 | 13篇 |
1981年 | 8篇 |
1980年 | 12篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1975年 | 3篇 |
1970年 | 2篇 |
1959年 | 1篇 |
排序方式: 共有3802条查询结果,搜索用时 0 毫秒
101.
102.
Ito Y Yoshida M Nakayama M Tsutaya S Ogawa K Maeda H Miyata M Oiso Y 《Internal medicine (Tokyo, Japan)》2012,51(1):83-86
A 47-year-old woman presented with hypokalemia (2.4 mmol/L). She also had hypomagnesemia, hypocalciuria, and hyperreninemic hyperaldosteronism. Sequence analysis revealed a compound heterozygous mutation, R655C and R955Q, in the SLC12A3 gene. These findings were compatible with Gitelman's syndrome (GS). Eplerenone, a selective aldosterone blocker, in combination with oral potassium chloride improved serum potassium level (3.6 mmol/L) with no apparent adverse effect. Although eplerenone has an advantage over spironolactone for its selective affinity for the aldosterone receptor, the efficacy and safety of eplerenone for GS is little understood. Our observation suggests that eplerenone is a useful treatment option for GS. 相似文献
103.
Calkins H Kuck KH Cappato R Brugada J Camm AJ Chen SA Crijns HJ Damiano RJ Davies DW DiMarco J Edgerton J Ellenbogen K Ezekowitz MD Haines DE Haissaguerre M Hindricks G Iesaka Y Jackman W Jalife J Jais P Kalman J Keane D Kim YH Kirchhof P Klein G Kottkamp H Kumagai K Lindsay BD Mansour M Marchlinski FE McCarthy PM Mont JL Morady F Nademanee K Nakagawa H Natale A Nattel S Packer DL Pappone C Prystowsky E Raviele A Reddy V Ruskin JN Shemin RJ Tsao HM Wilber D 《Europace : European pacing, arrhythmias, and cardiac electrophysiology》2012,14(4):528-606
104.
105.
106.
107.
Terao C Ohmura K Yamamoto K Yukawa N Kawabata D Nojima T Fujii T Mimori T 《Modern rheumatology / the Japan Rheumatism Association》2012,22(3):426-430
Hypergammaglobulinemia is often found in patients with autoimmune diseases, such as systemic lupus erythematosus (SLE), and its level may correlate with disease activity. However, it is unclear whether immunoglobulin G (IgG) displays seasonal changes. We analyzed the seasonal change in serum IgG by assessing 450 patients with connective tissue disease. The serum IgG levels in summer were compared with those in winter from 2006 to 2009. Independent samples from 355 patients were analyzed to confirm results in the first set. The differences in the IgG levels between the two seasons were analyzed in each disease and compared with disease activity. 488 patients without connective tissue disease were analyzed as reference instead of healthy people as control. We found that connective tissue disease patients tended to show higher levels of serum IgG in summer than in winter every year from 2006 to 2009, whereas patients without connective tissue disease did not demonstrate such a tendency. We observed this seasonal tendency in each disease. Seasonal changes weakly correlated with those of anti-DNA antibody in SLE patients and those of disease activity score in rheumatoid arthritis (RA) patients. Serum IgG levels of patients with connective tissue diseases display seasonal variations. Biological and clinical significance of these variations should be elucidated. 相似文献
108.
Matsui S Taki H Shinoda K Suzuki K Hayashi R Tobe K Tokimitsu Y Ishida M Fushiki H Seto H Fukuoka J Ishizawa S 《Modern rheumatology / the Japan Rheumatism Association》2012,22(1):31-39
'Immunoglobulin G4 (IgG4)-related disease' is a new clinical concept of multi-organ diseases, with Mikulicz's disease (MD) being a clinical phenotype of IgG4-related disease. To clarify the clinical characteristics of respiratory involvement associated with IgG4-related MD, we retrospectively assessed 25 patients with MD, 11 (44%) of whom had allergic symptoms, and 7 (28%) of whom complained of respiratory problems. Thirteen patients (52%) presented with pulmonary and/or mediastinal lesions (P-MD) on chest computed tomography (CT), and 11 (44%) had lesions limited to the lacrimal and/or salivary glands (L-MD). Mean serum total protein, IgG, and IgG4 concentrations were significantly higher and CH50 was significantly lower in the P-MD than in the L-MD group. Immune complex was present only in the P-MD group. Chest CT images showed bronchial wall thickening, consolidation, nodule(s), interlobular thickening, ground glass opacity, pleural thickening/effusion, and mediastinal lymphadenopathy. Five of seven patients who underwent histological examination of the lungs had abundant IgG4-positive plasma cell infiltrates (IgG4/IgG-positive plasma cells >40%), but the other two did not. These findings suggest that respiratory lesions are not rare in patients with IgG4-related MD, and that they present with various manifestations. IgG4-related MD should be differentiated from similar diseases, such as sarcoidosis, bronchial asthma, Sj?gren's syndrome, and malignant lymphoma. 相似文献
109.
Momohara S Inoue E Ikari K Yano K Tokita A Honjo Y Sakuma Y Hiroshima R Iwamoto T Seto Y Tanaka E Taniguchi A Yamanaka H 《Modern rheumatology / the Japan Rheumatism Association》2012,22(2):209-215
The treatment of rheumatoid arthritis (RA) has improved dramatically with the advent of the latest generation of disease-modifying antirheumatic drugs. Despite these advances, in some patients inflammation is not diminished sufficiently to prevent irreversible musculoskeletal damage, thereby necessitating surgical intervention to reduce pain and improve function. For RA treatment, Japanese orthopedic surgeons also prescribe medication. In this study, we examined whether this Japanese system is effective for RA treatment. We analyzed the clinical condition of RA patients treated by rheumatologists and those treated by orthopedists in a linked registry study using information from a large observational cohort of RA patients followed every half year from 2000 to 2010 (the IORRA cohort). Two groups of patients were compared: patients treated by rheumatologists (rheumatologic group) and patients treated by orthopedists (orthopedic group). The results revealed that patients in the orthopedic group were older, more likely to be female, and had a longer disease duration than patients in the rheumatologic group. The proportion of patients with a history of joint surgery was also much higher in the orthopedic group than in the rheumatologic group. The average scores on the Japanese version of the Health Assessment Questionnaire, and the remission ratio determined using a Boolean-based definition gradually increased from 2000 until 2010, and these findings were consistently better in the rheumatologic group than in the orthopedic group. These data suggest that patients treated primarily by orthopedists are more likely to have long-standing RA compared to patients treated by rheumatologists. Therefore, it is critical for rheumatologists and orthopedists to complement each other medically in the treatment of RA patients. 相似文献
110.